Company Filing History:
Years Active: 2018-2022
Title: François Mach: Innovator in Pharmaceutical Compositions
Introduction
François Mach is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at increasing HDL cholesterol levels. His work has implications for the treatment and prevention of various diseases.
Latest Patents
François Mach holds 2 patents related to his innovative pharmaceutical compositions. His latest patents focus on compositions based on methyl cyclodextrins for the treatment and/or prevention of diseases by increasing HDL cholesterol levels. The first patent discloses a pharmaceutical composition comprising at least one methyl cyclodextrin with a molar substitution degree between 0.05 and 1.5. This composition is designed to treat and prevent diseases that can be addressed by increasing HDL cholesterol levels. The second patent relates to a novel use of a similar pharmaceutical composition, emphasizing its potential in treating atherosclerosis and complications related to atheroma, as well as diseases of the central nervous system. Additionally, these compositions can stimulate the reduction of circulating fatty acids and triglyceride levels, helping to reduce or prevent atheromatous plaques.
Career Highlights
François Mach is associated with Roquette Frères, a company known for its expertise in food, nutrition, and pharmaceutical ingredients. His work at Roquette Frères has allowed him to focus on innovative solutions that address critical health issues.
Collaborations
François has collaborated with notable colleagues, including Marc Salome and Daniel Wils. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
François Mach's contributions to pharmaceutical innovations highlight the importance of research in improving health outcomes. His work continues to pave the way for new treatments that can significantly impact patient care.